ECLLA News
Welcome to ECLLA News, where we share updates on our work, key activities, and developments across the European CLL community. Stay informed about our initiatives, events, and efforts to strengthen collaboration and improve CLL care across Europe.
ECLLA Welcomes Its First UK Member: Lymphoma Action
ECLLA Welcomes Its First UK Member: Lymphoma Action The European CLL Association is delighted to welcome Lymphoma Action as its first member from the United Kingdom. Lymphoma Action is the UK’s leading charity dedicated to lymphoma, the most common type of blood...
ECLLA welcomes two new members: CLL Society (US) & Association of Cancer Patients in Finland
The European CLL Association (ECLLA) is pleased to welcome two new organisations to its growing international network: CLL Society and the Association of Cancer Patients in Finland. As ECLLA’s first Affiliated Member, CLL Society (US) brings global leadership in...
ECLLA welcomes two new members: Hematon (Netherlands) and LIPA (Serbia)
The European CLL Association is pleased to welcome two new organisations to its growing European network: Stichting Hematon from the Netherlands and the Lymphoma, CLL, MPN Patient Association – LIPA from Serbia. Both organisations bring valuable experience in patient...
ECLLA Co-founder Michael Rynne at the IPHA Conference in Dublin
European CLL Association (ECLLA) co-founder and association development lead, Michael Rynne attended the IPHA Conference in Dublin today, where he had the opportunity to meet with Jennifer Carroll MacNeill TD to discuss the pressing issues facing people living with...
Join ECLLA – Together for Equitable CLL Care in Europe!
The formation of the European CLL Association - ECLLA marks a critical step forward in addressing persistent inequalities in chronic lymphocytic leukemia care across Europe. By uniting clinicians, researchers, patient advocates and partners around a common mission...
🌍 World Cancer Day | 4 February
World Cancer Day is marked each year on 4 February to raise awareness of cancer and to encourage its prevention, early detection, and treatment. Today, we also highlight Chronic Lymphocytic Leukemia (CLL) — a type of blood cancer that affects the immune system and is...
ECLLA welcomes two new members: L&L (Slovenia) & AIL (Italy)
The European CLL Association (ECLLA) is pleased to welcome two new members, further strengthening our growing European network dedicated to improving outcomes for people living with Chronic Lymphocytic Leukemia (CLL). We are delighted to welcome: Slovenian Lymphoma...
ECLLA welcomes its first members and invites others to join
The European CLL Association (ECLLA) is proud to welcome its first members, marking an important milestone in building a unified European community dedicated to improving outcomes for people living with Chronic Lymphocytic Leukemia (CLL). These first members represent...
Advancing collaboration and equity in CLL care across Europe
At European CLL Association (ECLLA), our mission is clear: to improve outcomes for people living with Chronic Lymphocytic Leukemia (CLL) across the geographic region of Europe. CLL is the most common adult leukemia, yet access to diagnosis, treatment, supportive care,...